Gee -- I am not sure that's a compelling value, vis-a-vis streaming web-based re-runs of "Gilligan's Island" (free, of course!). In any event, here is a link to the sign-up screen, if you are so-inclined.
. . . .Oncologic Drugs Advisory Committee, Day 1 of 2, Committee Meeting on October 5, 2009 from 8:00 a.m. ET to 5:00 p.m. ET
Purchase Webcast [Price $140.00]
Agenda: The committee will discuss the following topics: (1) Supplemental biologics license application (sBLA) 103949/5153.0, PEGINTRON (peginterferon alfa-2b) injection, manufactured by Schering Corp. The proposed indication (use) for this product is as an adjuvant (additional) treatment for melanoma, a kind of skin cancer. The primary treatment for melanoma that is metastatic (has spread) to the lymph nodes is surgery to remove both the original cancer and lymph nodes surrounding the cancer. PEGINTRON's proposed use is as a treatment in addition to, or as an "adjuvant," to surgery. (2) New drug application (NDA) 022465, proposed trade name VOTRIENT (pazopanib) tablets, manufactured by GlaxoSmithKline. The proposed indication (use) for this product is for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.
PLEASE NOTE the October 6, 2009 meeting is CANCELED. . . .
From FDAAdvisoryCommittee.com
Jest' keepin' ya' informed, here.
2 comments:
Thanks for the theme music. I'll have to show the minnows.
I personally prefer the second season's version better, (the professor and mary ann).
But it just goes to show you what kind of guy Bob Denver was to insist on the other actors getting their due in the theme music.
Salmon
Agreed.
Namaste
Post a Comment